David P. Harding joined T2 Biosystems as Chief Commercial Officer in 2015. Prior to joining T2 Biosystems, David was Chief Commercial Officer at OvaScience, Inc., a biotech company focused on female fertility, where he focused on early stage commercialization. From 2004 to 2014, David was at Hologic, Inc., where he held roles of increasing responsibility ultimately leading to his position as Group Senior Vice President and General Manager of Women’s Health where he was responsible for $1.2B in revenue. Prior to Hologic, David was a partner at McKinsey & Company, a global management consulting firm. David holds a BS in Aerospace Engineering from the University of Southern California and an MBA from the Wharton School of the University of Pennsylvania.